Figure 3.

Univariate logistic regression analysis of factors associated with obstructive CAD in RA patients. (*p < 0.05, **p < 0.01, ***p < 0.001). OR, Odds ratio; 95%CI, 95% confidence interval; BMI, Body mass index; NSAIDs, Nonsteroidal antiinflammatory drugs; csDMARDs, Conventional synthetic disease-modifying antirheumatic drugs; bDMARD, Biological disease-modifying antirheumatic drug; GC, Glucocorticoid; DAS28, Disease activity score 28; ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein; RF, Rheumatoid factor; Anti-CCP, Anti-cycliccitrullinated peptide; WBC, White blood cell; RBC, Red blood cell; Hb, Hemoglobin; PLT, Platelet; LY, Lymphocyte; MONO, Monocyte; NEUT, Neutrophils; ALT, Alanine transaminase; AST, Aspartic transaminase; TBIL, Total bilirubin; DBIL, Direct bilirubin; IBIL, Indirect bilirubin; CHOL, Cholesterol; TG, Triglycerides; HDL-C, High density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; BUN, blood urea nitrogen; Cr, Creatinine; UA, Uric acid; IgA, Immunoglobulin A; IgG, Immunoglobulin G; IgM, Immunoglobulin M. T, T lymphocyte; B, B lymphocyte; NK, Natural killer cell; Th1, T-helper 1 cells; Th2, T-helper 2 cells; Th17, T-helper17 cells; Treg, Regulatory T cells.IL-2, Interleukin-2; IL-4, Interleukin-4; IL-6, Interleukin-6; IL-10, Interleukin-10; IL-17, Interleukin-17; INF-γ, Interferon-γ; TNF-α, Tumor necrosis factor-α.